Mendon, NY, United States of America

Rachael Turner

This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: University of Rochester. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rachael Turner. Retrieved from https://idiyas.com/inventor/rachael-turner

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Rachael Turner - Innovator in Cancer Treatment

Introduction

Rachael Turner is a prominent inventor based in Mendon, NY (US). She has made significant contributions to the field of cancer treatment through her innovative research and development of novel compounds.

Latest Patents

Rachael Turner holds 1 patent for her work on septin inhibitors for the treatment of cancers. The patent details the provision of novel compounds, compositions, and methods for modulating one or more septin proteins, such as septin-2. These compounds and compositions are particularly useful for treating various types of cancer, including endometrial, pancreatic, lung, breast, and ovarian cancers, specifically serous and ovarian clear cell carcinoma.

Career Highlights

Rachael is affiliated with the University of Rochester, where she continues her research and development efforts. Her work has garnered attention for its potential impact on cancer therapies and patient outcomes.

Collaborations

Some of her notable coworkers include Rakesh Kumar Singh and Kyu K Kim, who contribute to her research initiatives and collaborative projects.

Conclusion

Rachael Turner's innovative work in cancer treatment exemplifies the vital role of inventors in advancing medical science. Her contributions are paving the way for new therapeutic options for patients battling cancer.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…